1. Home
  2. RFL vs VCIG Comparison

RFL vs VCIG Comparison

Compare RFL & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • VCIG
  • Stock Information
  • Founded
  • RFL N/A
  • VCIG 2013
  • Country
  • RFL United States
  • VCIG Malaysia
  • Employees
  • RFL N/A
  • VCIG N/A
  • Industry
  • RFL Real Estate
  • VCIG Diversified Commercial Services
  • Sector
  • RFL Finance
  • VCIG Consumer Discretionary
  • Exchange
  • RFL Nasdaq
  • VCIG Nasdaq
  • Market Cap
  • RFL 36.1M
  • VCIG 30.2M
  • IPO Year
  • RFL N/A
  • VCIG 2023
  • Fundamental
  • Price
  • RFL $1.44
  • VCIG $0.44
  • Analyst Decision
  • RFL
  • VCIG
  • Analyst Count
  • RFL 0
  • VCIG 0
  • Target Price
  • RFL N/A
  • VCIG N/A
  • AVG Volume (30 Days)
  • RFL 32.5K
  • VCIG 305.3K
  • Earning Date
  • RFL 06-14-2024
  • VCIG 08-06-2024
  • Dividend Yield
  • RFL N/A
  • VCIG N/A
  • EPS Growth
  • RFL N/A
  • VCIG 61.67
  • EPS
  • RFL N/A
  • VCIG 0.21
  • Revenue
  • RFL $540,000.00
  • VCIG $19,781,731.00
  • Revenue This Year
  • RFL N/A
  • VCIG N/A
  • Revenue Next Year
  • RFL N/A
  • VCIG N/A
  • P/E Ratio
  • RFL N/A
  • VCIG $2.03
  • Revenue Growth
  • RFL 92.86
  • VCIG 91.25
  • 52 Week Low
  • RFL $1.29
  • VCIG $0.42
  • 52 Week High
  • RFL $2.52
  • VCIG $9.35
  • Technical
  • Relative Strength Index (RSI)
  • RFL 56.56
  • VCIG 26.18
  • Support Level
  • RFL $1.30
  • VCIG $0.48
  • Resistance Level
  • RFL $1.57
  • VCIG $0.53
  • Average True Range (ATR)
  • RFL 0.09
  • VCIG 0.04
  • MACD
  • RFL 0.01
  • VCIG -0.00
  • Stochastic Oscillator
  • RFL 85.71
  • VCIG 9.23

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development solution consultancy. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology Consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment which focuses on listing solutions, investor relations, and boardroom strategies consultancy. It has established a diverse local and international clientele, providing them with its services in both local and cross-border listings. Its role begins with pre-listing diagnosis and planning to the finalization of the entire listing process.

Share on Social Networks: